June 6, 2018
FDA: New labeling for liquid-filled intragastric balloons
Editor's Note
The Food & Drug Administration on June 4 announced that it had approved new labeling on potential risks for liquid-filled intragastric balloons by Apollo Endosurgery and ReShape Lifesciences.
The new labeling for the Orbera and ReShape balloon systems includes more information about possible deaths linked to the use of these devices.
Free Daily News
- Hospital margins improve as outpatient revenue accelerates, but costs loom
- Breast cancer surgery delays tied to higher upstaging, faster tumor growth
- Exercise programs ease stress and burnout for nurses, review finds
- WHO and robotic surgery society partner to expand global access to telesurgery
- Health systems lean toward established partners for AI adoption
- Immigration raids are driving patients back to telehealth and ERs
- Study: Global access to surgery deemed a crisis, leaves 160 million without care
- Large-scale studies link preoperative cognition to delirium risk, reveal its deadly toll after surgery
- Socioeconomic deprivation linked to lower fitness before surgery, UK study finds
- Perioperative medication decisions need individualized risk-benefit approach
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement